Late-stage RSV vaccine trials show 'exciting promise,' some scientists say

A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.

from CNN.com - RSS Channel - HP Hero https://ift.tt/YCEZFBw

Comments

Popular posts from this blog

What is the most profitable side hustle?

INFAMOUS: The Westside Park Murders

INFAMOUS: The Jeff Davis 8